The YDR271C antibody is a polyclonal antibody targeting the protein product of the YDR271C gene in Saccharomyces cerevisiae (Baker’s yeast). This gene is classified as a "dubious open reading frame" (ORF), meaning its functional relevance remains unconfirmed, though it has been implicated in protein interaction studies . The antibody is primarily used in research settings to investigate yeast genetics and proteomics.
The YDR271C gene encodes a hypothetical protein (UniProt ID: P87282) with no well-characterized functional domains. Key features include:
YDR271C was identified as a potential interactor of the mucin-type glycoprotein Msb2p in S. cerevisiae using protein microarrays . Though its role in this interaction remains unvalidated, the YDR271C antibody has been employed in preliminary assays to explore its localization and binding partners.
In a study analyzing histone H2A.Z (Htz1p) association with promoters, YDR271C was listed as a control target in ChIP experiments using an anti-Htz1 antibody . While YDR271C itself is not a histone-related gene, its inclusion suggests its use as a negative or technical control in genomic assays.
Dubious ORF Status: The lack of confirmed biological function for YDR271C limits the antibody’s utility in hypothesis-driven research .
Validation Gaps: As with many antibodies targeting uncharacterized proteins, reliability depends heavily on context-specific validation .
Niche Use Case: Primarily restricted to yeast proteomics studies, with no documented applications in therapeutic or industrial settings .
Further studies could clarify YDR271C’s role in yeast biology, leveraging CRISPR-based knockout models paired with this antibody to assess phenotypic or molecular changes. Improved validation protocols, such as mass spectrometry or orthogonal assays, would enhance confidence in its specificity .
YDR271C is a systematic designation for a yeast gene that appears to be studied in the context of chromatin remodeling complexes. Based on the research data, YDR271C is examined alongside key components of the SWR1 complex, particularly in relation to Arp6 and Swr1 proteins . These components play crucial roles in the incorporation of the histone variant Htz1 (equivalent to H2A.Z in higher eukaryotes) into chromatin.
The functional significance of YDR271C can be understood through its association with ribosomal protein genes and other genomic loci. Research indicates that the SWR1 complex, which may include or interact with YDR271C, is involved in regulating gene expression patterns, particularly at specific chromosomal locations as demonstrated by ChIP analyses .
When designing ChIP experiments with YDR271C antibodies, researchers should follow these methodological guidelines:
Crosslinking optimization: Use 1% formaldehyde for 10-15 minutes as a starting point, but optimize based on the strength of YDR271C-DNA interactions.
Include appropriate controls: Use wild-type, ydrc271c deletion mutants, and no-antibody controls to validate specificity.
Quantification methods: Implement real-time quantitative PCR for analyzing immunoprecipitated DNA, similar to the protocol used for Htz1 ChIP in the research data .
Experimental replication: Conduct at least three independent experiments to establish statistical significance, as demonstrated in the published protocols .
Data analysis: Report results as percentage of input DNA obtained by ChIP, presenting mean values with standard deviations across replicates .
Thorough validation of YDR271C antibody specificity requires multiple complementary approaches:
Genetic validation: Test antibody reactivity in wild-type versus ydrc271c deletion strains to confirm signal specificity.
Tagged protein controls: Compare results using anti-YDR271C antibody with those obtained using epitope-tagged versions (e.g., FLAG-tagged YDR271C), similar to the approach used for Arp6-FLAG and Swr1-FLAG in the literature .
Binding pattern analysis: Compare YDR271C binding patterns with those of known interacting partners or complex members to verify biological relevance.
Cross-reactivity assessment: Perform western blot analysis across multiple yeast strains to ensure the antibody does not detect unrelated proteins.
Peptide competition: Pre-incubate the antibody with immunizing peptide to confirm epitope-specific binding.
For optimal detection of YDR271C chromosomal localization, researchers should adopt a comprehensive approach:
ChIP-seq methodology:
Fragment chromatin to 200-500bp through optimized sonication
Immunoprecipitate with validated YDR271C antibody
Prepare sequencing libraries with appropriate controls
Apply rigorous bioinformatic analysis to identify binding sites
Visualization approach:
Validation of key sites:
Data representation:
Deletion mutant analysis provides critical insights into YDR271C function:
Impact on binding patterns:
Effects on gene expression:
Experimental approach:
Table 1: Example Gene Expression Changes in Deletion Mutants
| Gene | Wild-Type (Relative to ACT1) | arp6Δ (Relative to ACT1) | htz1Δ (Relative to ACT1) |
|---|---|---|---|
| RDS1 | 1.0 | 2.5 | 6.0 |
| UBX3 | 1.0 | 4.0 | 8.0 |
Note: Values approximated from Figure S8 in the research data
Robust ChIP-seq analysis for YDR271C should follow these best practices:
Quality control measures:
Assess sequencing depth and library quality
Calculate enrichment metrics (fraction of reads in peaks)
Evaluate replicate consistency using correlation analyses
Peak calling strategies:
Comparative analysis:
Functional annotation:
Investigating YDR271C's role in protein complexes requires sophisticated approaches:
Co-immunoprecipitation studies:
Use YDR271C antibody to pull down associated proteins
Identify interacting partners through mass spectrometry
Confirm interactions with reciprocal co-IPs using antibodies against suspected partners
Functional dependency analysis:
Structural studies:
Analyze the integration of YDR271C within larger complexes
Determine spatial relationships with other complex components
Identify domains critical for complex assembly and function
ChIP-reChIP approaches:
Use sequential ChIP to determine co-occupancy of YDR271C with other factors at specific genomic locations
Quantify co-localization frequency across the genome
For reliable quantification of YDR271C-associated chromatin changes:
Histone variant incorporation analysis:
Nucleosome positioning assays:
Use MNase-seq to map nucleosome positions in wild-type and mutant strains
Analyze changes in nucleosome occupancy and positioning
Correlate with YDR271C binding sites
Chromatin accessibility measurements:
Implement ATAC-seq to assess changes in chromatin accessibility
Compare accessibility profiles between wild-type and mutant strains
Identify regions where YDR271C activity affects chromatin structure
Gene association studies:
Modern computational approaches offer significant advantages for YDR271C antibody design:
AI-driven antibody generation:
Zero-shot antibody design:
High-throughput screening integration:
Structural prediction:
Use AlphaFold2 or similar tools to predict YDR271C structure
Design antibodies targeting specific epitopes with optimal accessibility
Model antibody-antigen complexes to optimize binding interactions
When facing inconsistent results with YDR271C antibodies, implement this systematic approach:
Antibody validation reassessment:
Confirm antibody specificity using genetic controls (ydrc271c strains)
Test multiple antibody lots or sources to identify batch variation
Validate epitope integrity and recognition in different experimental conditions
Experimental standardization:
Technical optimization:
Adjust antibody concentration and incubation conditions
Optimize extraction methods for nuclear/chromatin-bound proteins
Incorporate appropriate blocking reagents to reduce non-specific binding
Biological variability considerations:
Account for cell cycle effects on chromatin structure
Consider stress responses that may alter YDR271C localization or abundance
Integrate time-course experiments to capture dynamic changes
To resolve contradictory findings in YDR271C binding studies:
Methodological comparison:
Analyze differences in ChIP protocols that might affect outcomes
Compare antibodies used (monoclonal vs polyclonal, different epitopes)
Evaluate fixation and sonication conditions that impact chromatin preparation
Integrative analysis:
Orthogonal validation:
Confirm key findings using alternative techniques (CUT&RUN, DamID)
Implement genetic approaches to validate functional relationships
Perform expression analysis to connect binding with functional outcomes
Statistical rigor:
For proper interpretation of gene expression changes:
Experimental design considerations:
Data analysis framework:
Functional interpretation:
Mechanistic connections:
Analyze changes in histone variant incorporation at differentially expressed genes
Determine if gene positioning (nuclear periphery vs interior) correlates with expression changes
Investigate relationship between chromatin accessibility and expression changes
AI technologies are revolutionizing antibody design with particular relevance to chromatin factors:
Generative AI applications:
Sequence-structure relationships:
AI models generate antibodies with "high sequence diversity" and "low sequence identity to known antibodies"
These antibodies "adopt variable structural conformations" while maintaining target binding
This approach enables creation of antibodies against challenging targets like chromatin-associated proteins
Developability assessment:
High-throughput integration:
Future research should explore these promising directions:
Genome-wide functional analysis:
Comprehensive ChIP-seq mapping of YDR271C across diverse conditions
Integration with nucleosome positioning and histone modification data
Correlation with three-dimensional genome organization
Mechanistic investigations:
Structural studies of YDR271C within chromatin remodeling complexes
Single-molecule approaches to observe dynamics of YDR271C activity
CRISPR-based screens to identify genetic interactions
Translational connections:
Identification and characterization of YDR271C homologs in higher eukaryotes
Investigation of disease associations of human orthologs
Exploration of YDR271C-related pathways as therapeutic targets
Technological integration:
Application of AI-designed antibodies to study YDR271C with improved specificity
Implementation of CRISPR-based genomic editing to create precise mutations
Development of optogenetic tools to control YDR271C activity with spatiotemporal precision
Integrative multi-omics strategies offer powerful insights into YDR271C function:
Integrated genomics approach:
Combine ChIP-seq, RNA-seq, and ATAC-seq in wild-type and mutant backgrounds
Correlate YDR271C binding with expression changes and chromatin accessibility
Identify direct versus indirect effects through temporal studies
Proteomics integration:
Map YDR271C protein interactions through IP-mass spectrometry
Characterize post-translational modifications affecting YDR271C function
Quantify complex composition changes in different conditions
Metabolomics connections:
Computational integration:
Develop network models incorporating multiple data types
Apply machine learning to predict YDR271C binding sites and functional outcomes
Create visualization tools for integrated multi-omics data interpretation